Procurement Summary
Country: USA
Summary: Biotage Turbovap Lv Evaporation System 2Ea
Deadline: 10 Aug 2026
Posting Date: 05 Aug 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 146556554
Document Ref. No.: FDA-HFP-2026-134777-AMENDMENT1
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
The purpose of this procurement is to acquire two (2) solvent evaporation systems capable of high-throughput, reproducible, and efficient solvent evaporation during sample preparation. The systems shall be used to remove organic solvents from extracted samples, leaving concentrated residues for further analytical processing. The equipment shall improve laboratory efficiency,
reduce analyst handling time, and ensure consistent analyte concentration prior to instrumental analysis.
Notice ID: fda-hfp-2026-134777-amendment1
Department/Ind. Agency: health and human services, department of
Sub-tier: food and drug administration
Office: fda office of acq grant svcs
Product Service Code: r499 - support- professional: other
NAICS Code: 334516 - Analytical Laboratory Instrument Manufacturing
Inactive Dates: aug 10, 2026
Inactive Policy: manual
Documents
Tender Notice
Documents.zip